Claritin and Effient drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Claritin (loratadine) and Effient (prasugrel hydrochloride). Common drug interactions include gastrooesophageal reflux disease among females and myocardial infarction among males.
The phase IV clinical study analyzes what interactions people have when they take Claritin and Effient. It is created by eHealthMe based on reports of 32 people who take the same drugs from the FDA, and is updated regularly.
What is Claritin?
Claritin has active ingredients of loratadine. It is often used in allergies. eHealthMe is studying from 77,317 Claritin users. Check the latest studies of Claritin.
What is Effient?
Effient has active ingredients of prasugrel hydrochloride. It is often used in stent. eHealthMe is studying from 9,482 Effient users. Check the latest studies of Effient.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
32 people who take Claritin and Effient together, and have interactions are studied.

What are the common drug interactions of Claritin and Effient, by gender? *:
female:
- Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
- Hepatic enzyme increased
- Hypertension (high blood pressure)
- Hypoaesthesia (reduced sense of touch or sensation)
- Hypotension (abnormally low blood pressure)
- Insomnia (sleeplessness)
- Meniere's disease (a disorder of the inner ear that can affect hearing and balance to a varying degree)
- Muscle disorder (muscle disease)
- Muscle spasms (muscle contraction)
- Oxygen saturation decreased
male:
- Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
- Dizziness
- Abdominal discomfort
- Intervertebral disc protrusion (spinal disc protrusion)
- Local swelling (swelling at the site of some application of substance or injury)
- Pustular psoriasis (raised bumps on the skin that are filled with pus)
- Abdominal pain upper
- Back disorder
- Blood iron decreased
- Cataract (clouding of the lens inside the eye)
What are the common drug interactions of Claritin and Effient, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Muscle spasms (muscle contraction)
40-49:
- Memory impairment
- Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
50-59:
- Pustular psoriasis (raised bumps on the skin that are filled with pus)
- Abdominal discomfort
- Abdominal pain upper
- Cardiac failure congestive
- Diarrhoea
- Flatulence (flatus expelled through the anus)
- Gastrointestinal disorder (functional problems of gastrointestinal tract)
- Headache (pain in head)
- Local swelling (swelling at the site of some application of substance or injury)
- Onychoclasis (breaking of the nails)
60+:
- Interstitial lung disease
- Pyrexia (fever)
- Blindness
- Blood pressure fluctuation
- Blood pressure increased
- Body mass index increased
- Cardiac disorder
- Cataract (clouding of the lens inside the eye)
- Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
- Cough
What are the existing conditions these people have? *
- High Blood Cholesterol: 11 people, 34.38%
- Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 6 people, 18.75%
- Cataplexy (loss of muscle tone accompanied by full conscious awareness): 6 people, 18.75%
- High Blood Pressure: 5 people, 15.62%
- Type 2 Diabetes: 4 people, 12.50%
- Staphylococcal Sepsis (blood infection by an infection with staphylococcus bacteria): 4 people, 12.50%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 12.50%
- Diabetes: 3 people, 9.38%
- Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 3 people, 9.38%
- Dry Eyes (lack of adequate tears): 3 people, 9.38%
* Approximation only. Some reports may have incomplete information.
Do you take Claritin and Effient?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Claritin and Effient:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Claritin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Effient:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Claritin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Effient and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on loratadine and prasugrel hydrochloride (the active ingredients of Claritin and Effient, respectively), and Claritin and Effient (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Enalapril Maleate cause Neoplasm Progression? - 5 seconds ago
- Could Omeprazole cause Unintended Pregnancy? - 16 seconds ago
- Could Moxifloxacin Hydrochloride cause Protein - Urine? - 24 seconds ago
- Drug interactions of Vitamin B12 and Gaviscon - 27 seconds ago
- Could Phenergan cause Anal Fissure? - 28 seconds ago
- Could Avalide cause Feeling Abnormal? - 28 seconds ago
- Drug interactions of Rabeprazole Sodium and Micafungin Sodium - 29 seconds ago
- Could Pred Forte cause Hyperhidrosis? - 31 seconds ago
- Could Asa cause High Blood Cholesterol? - 32 seconds ago
- Could Asa cause Blood Glucose Decreased? - 41 seconds ago